CA2873018A1 - Compositions et methodes de traitement de la douleur moderee a aigue - Google Patents

Compositions et methodes de traitement de la douleur moderee a aigue Download PDF

Info

Publication number
CA2873018A1
CA2873018A1 CA2873018A CA2873018A CA2873018A1 CA 2873018 A1 CA2873018 A1 CA 2873018A1 CA 2873018 A CA2873018 A CA 2873018A CA 2873018 A CA2873018 A CA 2873018A CA 2873018 A1 CA2873018 A1 CA 2873018A1
Authority
CA
Canada
Prior art keywords
pain
compositions
administration
acid
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2873018A
Other languages
English (en)
Inventor
Mahesh Kandula
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cellix Bio Pvt Ltd
Original Assignee
Cellix Bio Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellix Bio Pvt Ltd filed Critical Cellix Bio Pvt Ltd
Publication of CA2873018A1 publication Critical patent/CA2873018A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02—Five-membered rings
    • C07D339/04—Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
CA2873018A 2012-07-03 2013-06-23 Compositions et methodes de traitement de la douleur moderee a aigue Abandoned CA2873018A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN2682/CHE/2012 2012-07-03
IN2682CH2012 2012-07-03
PCT/IB2013/055146 WO2014006529A2 (fr) 2012-07-03 2013-06-23 Compositions et méthodes de traitement de la douleur modérée à aiguë

Publications (1)

Publication Number Publication Date
CA2873018A1 true CA2873018A1 (fr) 2014-01-09

Family

ID=54188020

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2873018A Abandoned CA2873018A1 (fr) 2012-07-03 2013-06-23 Compositions et methodes de traitement de la douleur moderee a aigue

Country Status (8)

Country Link
EP (1) EP2870130A4 (fr)
JP (1) JP2015527309A (fr)
CN (1) CN104583162A (fr)
AU (1) AU2013285126A1 (fr)
CA (1) CA2873018A1 (fr)
SG (1) SG11201407328TA (fr)
WO (1) WO2014006529A2 (fr)
ZA (1) ZA201408057B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2847197A4 (fr) * 2012-05-07 2015-11-04 Cellix Bio Private Ltd Promédicaments d'agents antiplaquettaires
WO2016046674A1 (fr) * 2014-09-28 2016-03-31 Mohan M Alapati Compositions et procédés pour le traitement de douleur modérée à aiguë
CN105037241B (zh) * 2015-06-19 2018-02-23 上海上药新亚药业有限公司 1‑(2,6‑二氯苯基)‑2‑吲哚酮的合成工艺
CN111116391A (zh) * 2019-12-17 2020-05-08 浙江工业大学 一种2-[(2,6-二氯苯基)氨基]苯乙酸钠的制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL137301C (fr) * 1966-03-30
AU514991B2 (en) * 1976-05-26 1981-03-12 Commonwealth Of Australia, The Pharmaceutical compositions containing antiinflammatory analgesic compounds
LU78106A1 (de) * 1977-05-11 1979-05-23 Ciba Geigy Ag Verfahren zur herstellung neuer substituierter phenylessigsaeureamidverbindungen
JPS5412340A (en) * 1977-06-27 1979-01-30 Daito Koeki Process for preparing phenylacetate derivative
NL8602767A (nl) * 1986-10-31 1988-05-16 Gantax Nv Organisch zuuranhydride, alsmede farmaceutisch preparaat op basis van een prodrug.
MY118354A (en) * 1995-05-01 2004-10-30 Scarista Ltd 1,3-propane diol derivatives as bioactive compounds
JPH1143467A (ja) * 1997-05-14 1999-02-16 Ikeda Mohandou:Kk 脂肪酸グリセライド誘導体及びグリセライド誘導体、並びにそれらの製造方法
US6429223B1 (en) * 2000-06-23 2002-08-06 Medinox, Inc. Modified forms of pharmacologically active agents and uses therefor
CN101868443A (zh) * 2007-09-20 2010-10-20 特拉维夫大学拉莫特有限公司 N-苯基邻氨基苯甲酸衍生物及其用途
US20090082450A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched diclofenac
CN101186583B (zh) * 2007-12-20 2011-05-11 吉林大学 2-(2-(2,6-二氯苯基氨基)苯基)醋酸甲酯及其合成方法及其应用
BRPI0901298A2 (pt) * 2009-04-06 2011-01-04 Ems Sa derivados ftalimìdicos de compostos antiinflamatórios não-esteróide e/ou moduladores de tnf-(alfa), processo de sua obtenção, composições farmacêuticas contendo os mesmos e seus usos no tratamento de doenças inflamatórias
US9525998B2 (en) * 2012-01-06 2016-12-20 Qualcomm Incorporated Wireless display with multiscreen service
KR102094050B1 (ko) * 2012-01-27 2020-03-27 인터디지탈 패튼 홀딩스, 인크 다중 캐리어 기반형 및/또는 의사 조합형 네트워크에서 epdcch를 제공하는 시스템 및/또는 방법
EP2847197A4 (fr) * 2012-05-07 2015-11-04 Cellix Bio Private Ltd Promédicaments d'agents antiplaquettaires
JP2015519333A (ja) * 2012-05-07 2015-07-09 セリックスビオ プライヴェート リミテッド 神経疾患の治療のための組成物および方法
JP2015526385A (ja) * 2012-05-08 2015-09-10 セリックスビオ プライヴェート リミテッド てんかんの治療のための組成物及び方法
CA2872976A1 (fr) * 2012-05-08 2013-11-14 Cellixbio Private Limited Compositions et methodes de traitement de troubles neurologiques
WO2013167987A1 (fr) * 2012-05-08 2013-11-14 Mahesh Kandula Compositions et méthodes de traitement du diabète
AU2013257715B2 (en) * 2012-05-08 2016-05-05 Cellixbio Private Limited Compositions and methods for suppression of carbonic anhydrase activity

Also Published As

Publication number Publication date
WO2014006529A3 (fr) 2014-04-24
WO2014006529A2 (fr) 2014-01-09
CN104583162A (zh) 2015-04-29
AU2013285126A1 (en) 2014-11-27
JP2015527309A (ja) 2015-09-17
EP2870130A4 (fr) 2015-12-02
EP2870130A2 (fr) 2015-05-13
SG11201407328TA (en) 2014-12-30
ZA201408057B (en) 2016-03-30

Similar Documents

Publication Publication Date Title
US9434704B2 (en) Compositions and methods for the treatment of neurological degenerative disorders
US20150133533A1 (en) Compositions and methods for the treatment of cough
EP3201168B1 (fr) Composés et compositions pour le traitement de la sclérose en plaques
WO2014087367A2 (fr) Compositions et procédés pour le traitement de maladies neurologiques et de leurs complications associées
WO2014115098A1 (fr) Compositions et procédés pour le traitement de maladies neurologiques et d'une inflammation
US9403793B2 (en) Compositions and methods for the treatment of moderate to severe pain
US9580383B2 (en) Compositions and methods for the treatment of multiple sclerosis
WO2014068463A2 (fr) Compositions et procédés de traitement d'une inflammation et de troubles métaboliques
CA2873018A1 (fr) Compositions et methodes de traitement de la douleur moderee a aigue
WO2013167998A2 (fr) Compositions et méthodes de traitement de troubles autonomiques et autres troubles neurologiques
US20150218136A1 (en) Compositions and methods for the treatment of neurologic diseases
WO2014195850A2 (fr) Compositions et méthodes de traitement de maladies neurologiques et de troubles neurologiques
US9346742B2 (en) Compositions and methods for the treatment of fibromyalgia pain
WO2014057439A2 (fr) Compositions et procédés de traitement de maladies neurologiques et des complications associées
WO2014068459A2 (fr) Compositions et méthodes de traitement de la douleur et de maladies neurologiques
WO2015028956A1 (fr) Compositions et méthodes de traitement de troubles de l'oxydation des acides gras
US20150141384A1 (en) Compositions and methods for the treatment of neurological degenerative disorders
WO2014203198A2 (fr) Compositions et procédés de traitement de maladies neurologiques et de complications rénales
US20150141513A1 (en) Compositions and methods for the treatment of neurological degenerative disorders and neurological diseases
WO2014122575A2 (fr) Conjugués d'acide gras pour le traitement d'inflammations et de maladies métaboliques
US20150299117A1 (en) Compositions and methods for the treatment inflammation and lipid disorders
US20150087674A1 (en) Compositions and methods for the treatment of severe pain
WO2013168012A1 (fr) Compositions et méthodes de traitement de troubles respiratoires
WO2014060925A2 (fr) Compositions et méthodes de traitement de maladies neurologiques et neurodégénératives
WO2015001499A2 (fr) Compositions et procédés de traitement du syndrome du côlon irritable et des crampes abdominales associées

Legal Events

Date Code Title Description
FZDE Dead

Effective date: 20180626